A PROSPECTIVE STUDY TO COMPARE SINGLE DOSE INTRATHECAL COMBINATION OF BUPIVACAINE AND MORPHINE WITH FENTANYL, BUPIVACAINE AND MORPHINE FOR LABOUR ANALGESIA
Journal Title: Journal of Evolution of Medical and Dental Sciences - Year 2018, Vol 7, Issue 31
Abstract
BACKGROUND Advances in the field of labour analgesia have tread a long journey from the days of inhalation to the present-day practice. Low dose neuraxial blocks with local anaesthetic or opioids or combination of two give superior analgesia with lesser side effects and facilitate ambulation. MATERIALS AND METHODS This study was a non-randomised, controlled trial. There were 50 parturients of ASA physical status I or II with a term singleton foetus in a vertex position without any comorbidity were randomly divided into two groups of 25 each. Spinal analgesia was administered at L3-L4 or L4-L5 using a pencil point 25-G spinal needle in sitting position. Group I received injection Morphine 100 mcg + Inj. Bupivacaine 2.5 mg (.25%) and Group II received Inj. Fentanyl 15 mcg + 50 mcg Morphine + Inj. Bupivacaine 2.5 mg (.25%) intrathecally. We monitored changes in haemodynamics, duration of labour and degree of pain using VAP score (0-100 mm). Neonatal outcome was assessed by Apgar score at 1, 5 and 10 minutes interval. Maternal satisfaction and side effects like pruritus, nausea and hypotension were monitored. Since the calculated sample size was too high and thereby not feasible to include in this limited period of study, we had to limit the sample size for convenience. RESULTS Pain score was significantly less (‘P’ < 0.5) in Group II at 5, 60 and 120 minutes in both primigravida and multigravida. Mean duration of labour is comparable in active 1st and 3rd stage in both groups and it is significantly prolonged in 2nd stage of labour in Group I, i.e. 90.00 +/_ 41.23 minutes as compared to 58.55 +/_ 24.27 minutes in Group II. Apgar score was between 9 and 10 at 0, 1, 5 and 10 minutes in both groups. Pruritus was the most frequent side effect in 76% and 72% in Group I and II respectively. 32% patients in Group I and 24% patients in Group II were unsatisfied. CONCLUSION We conclude that a single dose spinal block with Fentanyl 15 mcg + 50 mcg Morphine + Inj. Bupivacaine 2.5 mg (.25%) provide a rapid onset, profound analgesia with less side effects and good maternal satisfaction without affecting neonatal outcome.
Authors and Affiliations
Jyoti Sharma, Sanjeev Kumar
Keywords
Related Articles
- EP ID EP539121
- DOI 10.14260/jemds/2018/780
- Views 83
- Downloads 0
GALLBLADDER PERFORATION- PRESENTING AS AN ACUTE ABDOMEN
BACKGROUND Gallbladder perforation is a rare but life-threatening complication of acute cholecystitis. About 2% to 15% of patients with acute cholecystitis may be complicated with perforation of gallbladder. It may prese...
EFFICACY OF ARTICAINE VERSUS LIDOCAINE, AS A BUCCAL INFILTRATION COMBINED WITH INTRALIGAMENTARY INJECTION, IN MANDIBULAR MOLARS WITH IRREVERSIBLE PULPITIS- A CLINICAL TRIAL STUDY
BACKGROUND Pain should be controlled before dental procedure, which is an essential step in reducing anxiety and fear. Local anaesthesia plays an important role in pain control before any endodontic treatment. Most commo...
PROSPECTIVE STUDY OF BIPLANAR FIXATION FOR TYPE V AND TYPE VI CONDYLAR FRACTURES OF TIBIA BY MIPPO TECHNIQUE
BACKGROUND Treating complex Tibial Plateau Fractures has often proved to be a nightmare for the operating surgeon. Treatment has evolved from non-operative treatment previously to relatively rigid internal fixation at pr...
EPIDEMIOLOGICAL STUDY OF MEASLES IN BIHAR
[b] CONTEXT[/b]: Measles is one of the leading causes of death in young children despite the availability of safe and effective vaccine. There is need to fasten the immunization project in Bihar in order to decr...
COMPARISON OF CLINICO-PATHOLOGICAL FEATURES AND PROGNOSIS OF TRIPLE-NEGATIVE AND NON-TRIPLE-NEGATIVE FEMALE BREAST CANCER PATIENTS
BACKGROUND Triple-negative breast cancer patients have no expression of Oestrogen Receptor (ER), Progesterone Receptor (PR) and there is neither expression nor amplification of human epidermal growth factor receptor 2 in...